We have demonstrated that pharmacological blockade of AT-II and AT1R signaling by these agents significantly suppressed tumor growth and angiogenesis with reduced intratumor VEGF production in a mouse HCC allograft model [19]. Here, AGTR1 is linked to hepatocellular carcinoma.